Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial
Lee Seung-jin, Head of Medipost’s Global Business Division and CEO of its Japanese subsidiary, is speaking at a press conference to announce the results of the Phase 3 clinical trial for Cartistem in Japan, held on Wednesday at the Four Seasons Hotel in Jongno-gu, Seoul 2026.5.13 / News1
